Prostate cancer patients who receive permanent radiotherapy implants twice as likely to be free of cancer after five years
Results from a randomised controlled trial to compare the use of permanent radioactive implants (brachytherapy) with dose-escalated external beam radiotherapy in patients with prostate cancer show that the men who received brachytherapy were twice as likely to be cancer-free five years later.
Source: ScienceDaily Headlines - Category: Science Source Type: news
More News: Brachytherapy | Cancer | Cancer & Oncology | External Beam Therapy | Prostate Cancer | Science